Drug Development

Final results of phase I/II trial of AVR118 presented

Published in AIDS Weekly, February 21st, 2005

Advanced Viral Research Corp. (ADVR) announced that the company presented final results of its phase I/II clinical trial of AVR118 in patients with AIDS at the 2005 Annual Assembly of the American Academy of Hospice and Palliative Medicine (AAHPM) and Hospice and Palliative Nurses Association (HPNA) in New Orleans, Louisiana.

The presentation "Efficacious Reversal of AIDS Related Anorexia/Cachexia Syndrome: Final Results of a phase I/II Study Using a Novel Peptide-Nucleic Acid Complex" given by James T. D'Olimpio, MD, on January 22, 2005, showed the results of a phase I/II clinical trial conducted in Israel at the Kaplan Medical Center.

A total of 30...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-02-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry